Werner Scheuer

3.1k total citations
59 papers, 2.3k citations indexed

About

Werner Scheuer is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Werner Scheuer has authored 59 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 22 papers in Radiology, Nuclear Medicine and Imaging and 16 papers in Oncology. Recurrent topics in Werner Scheuer's work include Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (12 papers) and HER2/EGFR in Cancer Research (9 papers). Werner Scheuer is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (17 papers), Glycosylation and Glycoproteins Research (12 papers) and HER2/EGFR in Cancer Research (9 papers). Werner Scheuer collaborates with scholars based in Germany, Switzerland and United States. Werner Scheuer's co-authors include Thomas Friess, Max Hasmann, Josef Endl, Birgit Bossenmaier, Helmut Burtscher, Christian Klein, Michael Dobosz, Markus Thomas, Christian Gassner and Vasilis Ntziachristos and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Werner Scheuer

58 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Werner Scheuer 1.1k 920 885 470 241 59 2.3k
Rosaria Orlandi 1.5k 1.4× 706 0.8× 599 0.7× 525 1.1× 385 1.6× 61 2.7k
Judith P. Johnson 1.8k 1.7× 622 0.7× 1.0k 1.2× 1.3k 2.7× 367 1.5× 67 3.6k
Francesca Walker 1.9k 1.8× 965 1.0× 1.6k 1.8× 677 1.4× 214 0.9× 54 3.5k
Thomas Chittenden 1.8k 1.7× 500 0.5× 1.5k 1.7× 525 1.1× 328 1.4× 25 3.4k
Delia Mezzanzanica 2.0k 1.9× 897 1.0× 1.3k 1.4× 1.0k 2.2× 889 3.7× 107 3.9k
Valerie Quarmby 1.6k 1.5× 1.2k 1.3× 496 0.6× 1.3k 2.8× 98 0.4× 64 3.5k
Lloyd M. Stoolman 1.6k 1.5× 549 0.6× 607 0.7× 1.5k 3.1× 205 0.9× 59 3.5k
Debra L. Dugger 2.7k 2.5× 1.3k 1.4× 1.7k 1.9× 1.1k 2.4× 415 1.7× 24 4.3k
Peter B. Alexander 1.3k 1.3× 217 0.2× 721 0.8× 421 0.9× 479 2.0× 41 2.5k
Jessica R. Kirshner 842 0.8× 330 0.4× 1.6k 1.8× 403 0.9× 204 0.8× 37 2.6k

Countries citing papers authored by Werner Scheuer

Since Specialization
Citations

This map shows the geographic impact of Werner Scheuer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Werner Scheuer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Werner Scheuer more than expected).

Fields of papers citing papers by Werner Scheuer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Werner Scheuer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Werner Scheuer. The network helps show where Werner Scheuer may publish in the future.

Co-authorship network of co-authors of Werner Scheuer

This figure shows the co-authorship network connecting the top 25 collaborators of Werner Scheuer. A scholar is included among the top collaborators of Werner Scheuer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Werner Scheuer. Werner Scheuer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Scheuer, Werner, Markus Thomas, P Hanke, et al.. (2016). Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2. mAbs. 8(3). 562–573. 19 indexed citations
2.
Schanzer, Jürgen, Ute Jucknischke, Natalie J. Neubert, et al.. (2016). TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations. Protein Engineering Design and Selection. 29(10). 467–475. 19 indexed citations
3.
Weber, Thomas G., et al.. (2014). Apoptosis Imaging for Monitoring DR5 Antibody Accumulation and Pharmacodynamics in Brain Tumors Noninvasively. Cancer Research. 74(7). 1913–1923. 12 indexed citations
4.
5.
Kienast, Yvonne, Christian Klein, Werner Scheuer, et al.. (2013). Ang-2-VEGF-A CrossMab, a Novel Bispecific Human IgG1 Antibody Blocking VEGF-A and Ang-2 Functions Simultaneously, Mediates Potent Antitumor, Antiangiogenic, and Antimetastatic Efficacy. Clinical Cancer Research. 19(24). 6730–6740. 143 indexed citations
6.
Weber, Thomas G., Thomas Pöschinger, Stefanie Galbán, Alnawaz Rehemtulla, & Werner Scheuer. (2013). Noninvasive Monitoring of Pharmacodynamics and Kinetics of a Death Receptor 5 Antibody and Its Enhanced Apoptosis Induction in Sequential Application with Doxorubicin. Neoplasia. 15(8). 863–874. 13 indexed citations
7.
8.
Schaefer, Wolfgang, Jörg T. Regula, Monika Bähner, et al.. (2011). Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies. Proceedings of the National Academy of Sciences. 108(27). 11187–11192. 334 indexed citations
9.
Scheuer, Werner, Thomas Friess, Helmut Burtscher, et al.. (2009). Strongly Enhanced Antitumor Activity of Trastuzumab and Pertuzumab Combination Treatment on HER2-Positive Human Xenograft Tumor Models. Cancer Research. 69(24). 9330–9336. 460 indexed citations
10.
Friess, Thomas, Werner Scheuer, & Max Hasmann. (2007). Combinations of trastuzumab with either pertuzumab or bevacizumab show higher efficacy than lapatinib-based combinations against HER2-positive breast cancer xenografts progressing on trastuzumab monotherapy. Molecular Cancer Therapeutics. 6.
11.
Friess, Thomas, Werner Scheuer, & Max Hasmann. (2006). Erlotinib antitumor activity in non-small cell lung cancer models is independent of HER1 and HER2 overexpression.. PubMed. 26(5A). 3505–12. 14 indexed citations
12.
Schneider, Tanja, et al.. (2002). Quantification of human Alu sequences by real-time PCR – an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants. Clinical & Experimental Metastasis. 19(7). 571–582. 56 indexed citations
13.
Burgermeister, Elke, Ulrich Pessara, Ulrich Tibes, et al.. (2000). Inhibition of cytosolic phospholipase A2 attenuates activation of mitogen-activated protein kinases in human monocytic cells. European Journal of Pharmacology. 388(3). 195–208. 11 indexed citations
14.
Tibes, Ulrich, et al.. (1999). Phospholipase A2 is Involved in Chemotaxis Of Human Leukocytes. Advances in experimental medicine and biology. 469. 189–197. 4 indexed citations
15.
Tibes, Ulrich, et al.. (1999). Supression of Acute Experimental Inflammation by Antisense Oligonucleotides Targeting Secretory Phospholipase A2 (sPLA2)IN VITRO and IN VIVO Experiments. Advances in experimental medicine and biology. 469. 199–207. 2 indexed citations
16.
Thierse, Hermann‐Josef, et al.. (1996). Evidence for Activation of Cyclooxygenase-1/-2 by Endogenous Nitric Oxide in Adjuvant Arthritic Lewis Rats. Advances in experimental medicine and biology. 416. 343–348. 2 indexed citations
17.
Tibes, Ulrich, et al.. (1995). Inhibition of Allergic and IMon Allergic Inflammation by Phospholipase A<sub>2</sub> Inhibitors. International Archives of Allergy and Immunology. 107(1-3). 432–434. 13 indexed citations
18.
Tibes, Ulrich, et al.. (1994). Induction of cytosolic phospholipase A2 in human leukocytes by lipopolysaccharide. European Journal of Biochemistry. 223(3). 743–749. 21 indexed citations
19.
Kubbies, Manfred, et al.. (1989). Complex Ca2+ flux inhibition as primary mechanism of staurosporine‐induced impairment of T cell activation. European Journal of Immunology. 19(8). 1393–1398. 16 indexed citations
20.
Scheuer, Werner. (1989). Phospholipase A2 — Regulation and inhibition. Journal of Molecular Medicine. 67(3). 153–159. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosaria Orlandi Breakdown of academic impact, for papers by Judith P. Johnson Breakdown of academic impact, for papers by Francesca Walker Breakdown of academic impact, for papers by Thomas Chittenden Breakdown of academic impact, for papers by Delia Mezzanzanica Breakdown of academic impact, for papers by Valerie Quarmby Breakdown of academic impact, for papers by Lloyd M. Stoolman Breakdown of academic impact, for papers by Debra L. Dugger Breakdown of academic impact, for papers by Peter B. Alexander Breakdown of academic impact, for papers by Jessica R. Kirshner
Rankless by CCL
2026